Authors: Degan, M Mazzocco, FT Di Francia, R Rossi, FM Pinto, A Gattei, V

Citation: M. Degan et al., Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta(2)-microglobulin: Molecular monitoring of minimal residual disease in acute promyelocytic leukemia, DIAGN MOL P, 9(2), 2000, pp. 98-109

Authors: Gattei, V Degan, M Rossi, FM de Iuliis, A Mazzocco, FT Serraino, D Zagonel, V Aldinucci, D Pinto, A

Citation: V. Gattei et al., CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation, LEUK LYMPH, 35(1-2), 1999, pp. 21-35

Authors: Gattei, V Degan, M Rossi, FM De Iuliis, A Mazzocco, FT Cesa, E Aldinucci, D Zagonel, V Pinto, A

Citation: V. Gattei et al., The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation, BR J HAEM, 105(1), 1999, pp. 225-240

Authors: Horie, R Gattei, V Ito, K Imajo-Ohmi, S Tange, T Miyauchi, J Pinto, A Degan, M De Iuliis, A Mazzocco, FT Rossi, FM Higashihara, M Watanabe, T

Citation: R. Horie et al., Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms, AM J PATH, 155(6), 1999, pp. 2029-2041

Authors: Gattei, V Degan, M Aldinucci, D De Iuliis, A Rossi, FM Mazzocco, FT Rupolo, M Zagonel, V Pinto, A

Citation: V. Gattei et al., Differential expression of the RET gene in human acute myeloid leukemia, ANN HEMATOL, 77(5), 1998, pp. 207-210